BAL0891tislelizumabtriple-negative breast cancerTTK-CS-101paclitaxeladvanced solid tumors
… tolerated dose (MTD) and/or recommended Phase 2 dose (RP2D) of BAL0891 monotherapy and combination with paclitaxel.Trial Registration …
Browse by entity family
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Funders
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentions29,499matching articles
244,054matching entity mentions
30popular entities listed
0%of mentions human-reviewed
Popular entities in these results
Choose an entity to see the articles in which it was identified.
EMBASE784PUBMED717COVID-19645Cancer605SLE570Diabetes552NHS522WEB OF SCIENCE499Hypertension418SCOPUS417HIV406Systemic Lupus Erythematosus390Heart Failure364Asthma349Stroke336COPD331WHO330Colorectal Cancer327Cardiovascular Disease317Type 2 Diabetes316Chronic Obstructive Pulmonary Disease313Joanna Briggs Institute306MEDLINE306Atrial Fibrillation283Cochrane Library275Breast Cancer271Hepatocellular Carcinoma253SSc251Inflammatory Bowel Disease250Obesity246
Matching articles
29,499 articles · page 65 of 2459head and neck squamous cell carcinomapembrolizumabHead and neck squamous cell carcinoma (HNSCC)University of California San DiegoGerman Research FoundationNivolumabGleiberman Head and Neck Cancer CentercetuximabPD-1imethotrexate+2 more
… biomarker-unselected patients with recurrent and/or metastatic head and neck squamous cell carcinoma: results from the phase Ib KEYNOTE-012 expansion cohort. J Clin…
rituximabobinutuzumabOBZShanghai Jiao Tong University School of MedicineNPSLERTXRenji HospitalNeuropsychiatric SLE
…the effectiveness and safety profiles of obinutuzumab (OBZ) and rituximab (RTX) in patients with NPSLE.Methods Patients with new-onset NP…
silicosisTBsilicosis-exposedtuberculosis
…han the general population, with a higher risk among those with silicosis. This excess TB mortality, greater than expected from increased…
asthmaformoterolBDP-FBudesonide-formoterolBUD-Fbeclometasone-formoterolOptimum Patient Care Research Database
…ing the Optimum Patient Care Research Database, UK. Adults with asthma, no other chronic respiratory condition, and ≥1 year GP registr…
fibromyalgiaEQ-5D-3LEuroQol-5D-3LspondyloarthritisEQ-5DSpA
…-5D-3L q5; β=−0.147, 95% CI −0.160 to −0.134) and fibromyalgia (fibromyalgia rapid screening tool; β=−0.068, 95% CI −0.083 to −0.053) were s…
hsCRPmetabolic syndromeaICASMetS
…ntly associated with the risk of aICAS. The mediating effect of hsCRP on the relationship between MetS and aICAS appears to be age-de…
HIVtenofovirTruvadaemtricitabinePrEP
…(PrEP) with tenofovir and emtricitabine (Truvada) into national HIV guidelines as part of a comprehensive HIV prevention programme …
herpes zosterautoimmune rheumatic diseasestype 2 diabetesinflammatory arthritisautoimmune rheumatic diseaseconnective tissue diseasessulfonylureasSGLT-2 inhibitors
…rthritis and connective tissue diseases. Genital infections and herpes zoster were used as positive and negative control outcomes, respective…
advanced chronic liver diseasedecompensated liver diseaseKing’s College Hospitalferric carboxymaltose (FCM)FCMIron deficiency anaemia (IDA)hypophosphataemiaFDIIV iron replacementferric derisomaltose (FDI)
… major cause of morbidity and burden of disease worldwide. 1 In advanced chronic liver disease, two thirds of patients experience anaemia, with 7% having seve…
Hereditary haemochromatosisViral hepatitisPrimary biliary cholangitisNottingham University Hospitals NHS TrustCBPAPAutoimmune hepatitisMASLDHepatocellular carcinomalocal governmentAlcohol-related liver disease
…iral hepatitis 2 (3%), Drug-induced liver injury (DILI) 1 (2%), Hereditary haemochromatosis (HH) 1 (2%) and other 5 (8%). Severity of CLD included Cirrhosi…